|
Use of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Real-World Issues |
1.00 |
06/25/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Updates in the Management of Tumor Lysis Syndrome |
0.73 |
11/01/2019 - 12:00am to 10/31/2020 - 12:00am |
|
Trimodal Therapy Approaches for Localized Rectal Cancer |
0.75 |
05/27/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Treatment Considerations in Older Adult Oncology |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
|
The Role of Integrative Medicine in Cancer |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
|
The Role of Biosimilars in Cancer Treatment |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Talking to Patients about Cancer Treatment, Risk Factors, and Treatment Cessation during the COVID-19 Pandemic |
1.00 |
04/20/2020 - 12:00am to 04/20/2021 - 12:00am |
|
Survivorship Needs of Patients Living with Chronic Metastatic Disease |
1.00 |
05/21/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Surgical Management of Breast Cancer, Including SABCS Updates |
0.56 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
|
Smoking Cessation in Patients with Cancer |
0.76 |
12/17/2019 - 12:00am to 12/17/2020 - 12:00am |
|
Sequencing Therapy for Patients with Lung Cancer |
0.75 |
06/09/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Selection of Optimal First-Line and Maintenance Therapies in Advanced Ovarian Cancer |
1.00 |
07/08/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Role of Biosimilars in the Oncology Ecosystem |
1.25 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Role of Biomarkers in Individualizing Treatment Selection for Patients with Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Recorded Presentations from the NCCN 2020 Congress Series: Breast Cancer |
|
03/13/2020 - 12:00am to 03/15/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward